HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randomized, double-blind, placebo-controlled trial using lidocaine patch 5% in traumatic rib fractures.

AbstractBACKGROUND:
The lidocaine patch 5% was developed to treat postherpetic neuralgia. Anecdotal experience at our institution suggests the lidocaine patch 5% decreases narcotic usage in patients with traumatic rib fractures. This trial was developed to define the patch's efficacy.
STUDY DESIGN:
Patients with rib fractures admitted to the trauma service at our Level I trauma center were enrolled and randomized in a 1 to 1 double-blind manner to receive a lidocaine patch 5% or placebo patch. Fifty-eight patients who met the inclusion criteria were enrolled from January 2007 to August 2008. Demographic and clinical information were recorded. The primary outcomes variable was total narcotic use, analyzed using the 1-tailed Mann-Whitney test. The secondary outcomes variables included non-narcotic pain medication, average pain score, pulmonary complications, and length of stay. Significance was defined based on a 1-sided test for the primary outcome and 2-sided tests for other comparisons, at p < 0.05.
RESULTS:
Thirty-three patients received the lidocaine patch 5% and 25 received the placebo patch. There were no significant differences in age, number of rib fractures, gender, trauma mechanism, preinjury lung disease, smoking history, percent of current smokers, and need for placement of chest tube between the lidocaine patch 5% and placebo groups. There was no difference between the lidocaine patch 5% and placebo groups, respectively, with regard to total IV narcotic usage: median, 0.23 units versus 0.26 units; total oral narcotics: median, 4 units versus 7 units; pain score: 5.6 +/- 0.4 versus 6.0 +/- 0.3 (mean +/- SEM); length of stay: 7.8 +/- 1.1 versus 6.2 +/- 0.7; or percentage of patients with pulmonary complications: 72.7% versus 72.0%.
CONCLUSIONS:
The lidocaine patch 5% does not significantly improve pain control in polytrauma patients with traumatic rib fractures.
AuthorsNichole K Ingalls, Zachary A Horton, Matthew Bettendorf, Ira Frye, Carlos Rodriguez
JournalJournal of the American College of Surgeons (J Am Coll Surg) Vol. 210 Issue 2 Pg. 205-9 (Feb 2010) ISSN: 1879-1190 [Electronic] United States
PMID20113941 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Anesthetics, Local
  • Narcotics
  • Lidocaine
Topics
  • Administration, Cutaneous
  • Adult
  • Anesthetics, Local (administration & dosage)
  • Double-Blind Method
  • Female
  • Humans
  • Length of Stay
  • Lidocaine (administration & dosage)
  • Male
  • Middle Aged
  • Multiple Trauma (complications, diagnosis, therapy)
  • Narcotics (administration & dosage)
  • Pain (diagnosis, drug therapy, etiology)
  • Pain Measurement
  • Rib Fractures (complications, diagnosis, therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: